For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Myeloid Therapeutics, Inc.

USPTO Granted Patents = 12

Forward Citations = 31

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Daniel Getts (9 out of 9 patents)

Yuxiao Wang (9 out of 9 patents)

Boris Minev (3 out of 9 patents)

4. Amit N Patel (3 out of 23 patents)

5. Santosh Kesari (3 out of 9 patents)

6. Samuel C Wagner (3 out of 4 patents)

7. Thomas E Ichim (3 out of 3 patents)

8. Julia S Szymanski (3 out of 3 patents)

9. Inna Shcherbakova (2 out of 2 patents)

10. Namita Bisaria (2 out of 3 patents)

11. Socheata Ly (2 out of 2 patents)

12. Bruce McCreedy, Jr (2 out of 2 patents)

12 patents: Sort by Forward Citations

1. 12319925 - Methods and compositions for genomic integration (2025-06-03),

2. 12252545 - Therapeutic cell compositions and methods of manufacturing and use thereof (2025-03-18),

3. 12030938 - Engineered chimeric fusion protein compositions and methods of use thereof (2024-07-09),

4. 11944680 - Engineered chimeric fusion protein compositions and methods of use thereof (2024-04-02),

5. 11918605 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2024-03-05),

6. 11918604 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2024-03-05),

7. 11672874 - Methods and compositions for genomic integration (2023-06-13),

8. 11628218 - Engineered chimeric fusion protein compositions and methods of use thereof (2023-04-18),

9. 11517589 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2022-12-06),

10. 11026973 - Engineered phagocytic receptor compositions and methods of use thereof (2021-06-08),

11. 11013764 - Engineered phagocytic receptor compositions and methods of use thereof (2021-05-25),

12. 10980836 - Therapeutic cell compositions and methods of manufacturing and use thereof (2021-04-20),

Myeloid Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics for myeloid-related diseases. Our innovative approach targets the myeloid cell population to treat a variety of conditions, including cancer, autoimmune disorders, and inflammatory diseases. We are dedicated to advancing the field of myeloid cell therapy to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#171 in Boston, MA

#1,504 in Massachusetts

#24,841 in US

#46,762 in the World

Boston, MA, United States of America

Myeloid Therapeutics, Inc.

Forward Citations = 31

12 inventors:

Daniel Getts (9 out of 9 patents)

Yuxiao Wang (9 out of 9 patents)

Boris Minev (3 out of 9 patents)

4. Amit N Patel (3 out of 23 patents)

5. Santosh Kesari (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…